Kyle King
Optometrist · Evansville, INNPI 1598051948
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,402 of the $8,996 with a category attached, or 60.0%. 21 manufacturers reported payments, led by Alcon at 58.5% of the total. Reporting peaked in 2019 at $4,146 and has fallen 78.9% since, to $875 in 2025. Among optometrist clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $64.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$5K
- Bausch & Lomb Americas Inc.$851
- Bausch & Lomb, A Division Of Bausch Health US, LLC$506
- AbbVie$298
- Biotissue Holdings Inc.$250
- Sun Pharmaceutical Industries Inc.$245
- plus $2K from 15 others
What the payments were for
- Consulting fees$1,80520%
- Speaking & faculty fees$4355%
- Travel & lodging$1,28514%
- Food & beverage$5,40260%
- Entertainment$701%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 53 | $5,265 |
| Bausch & Lomb Americas Inc. | 21 | $851 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 20 | $506 |
| AbbVie(2 entities) | 4 | $298 |
| Biotissue Holdings Inc. | 2 | $250 |
| Sun Pharmaceutical Industries Inc. | 5 | $245 |
| Coopervision Inc. | 4 | $219 |
| Oyster Point Pharma, Inc. | 4 | $189 |
| Mallinckrodt Hospital Products Inc. | 3 | $172 |
| Optos, Inc. | 3 | $141 |
| Tarsus Pharmaceuticals, Inc. | 3 | $130 |
| Rxsight Inc | 2 | $130 |
| Glaukos Corporation | 3 | $123 |
| LKC Technologies, Inc. | 1 | $117 |
| Maculogix, Inc. | 2 | $95 |
| Aerie Pharmaceuticals, Inc. | 2 | $77 |
| Astellas Pharma US Inc | 1 | $72 |
| Novartis | 2 | $42 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Johnson & Johnson Vision Care, Inc. | 2 | $25 |
| Carl Zeiss Meditec USA, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES$2,732
- AIR OPTIX$435
- Air Optix plus HydraGlyde$435
- Dailies Aqua Comfort Plus$435
- DAILIES TOTAL1$435
- Precision 1$435
- Prokera$250
- AmnioGraft$250
- TRYPTYR$150
- Clareon$149
- ACTHAR$129
- TYRVAYA$125
- CEQUA$118
- Precision7$117
- MiSight Contact Lens$116
- MIEBO$103
- XIIDRA$103
- LUMIGAN$101
How this compares
$8,996 in reported general payments places this provider in the 95th percentile of 1,318 optometrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MieboPerfluorohexyloctane/Pf | 20 | $14,611 |
| LumiganBimatoprost | 13 | $6,342 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 12 | $1,043 |
| Epinastine Hcl | 11 | $553 |
| Latanoprost | 16 | $147 |
| Azelastine Hcl | 13 | $136 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $96 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Miebo | $851 | $14,61120 claims |
| AbbVieLumigan | $298 | $6,34213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,318 optometrist providers in Indiana.
Other optometrist in Evansville
- Walter EgenmaierEvansville$7K
- Christopher AmbroseEvansville$6K
- Stefan HanishEvansville$6K
- Damon DierkerIndianapolis$707K
- Jason JedlickaBloomington$456K
- Kari RiinaFishers$308K
- Rhonda RobinsonIndianapolis$205K
- John CzajaMerrillville$189K
- Peter KollbaumBloomington$60K
- Ryan GustusBluffton$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.